Influenza vaccine: Kids

Who:

RECOMMENDED annually for children age >6 months with certain risk factors:

• including but not limited to children with asthma, cardiac disease, sickle cell disease, human immunodeficiency virus infection, and diabetes;
• and household members of persons in high-risk groups

Healthy children age 6 to 23 months are ENCOURAGED to receive influenza vaccine if feasible

Can OPTIONALLY be administered to all others wishing to obtain immunity.

How:

Children receiving TIV should be administered a dosage appropriate for their age

• 0.25 mL if age 6 to 35 months
• 0.5 mL if age >3 years

Children age <8 years who are receiving influenza vaccine for the first time should receive TOTAL AMOUNT delivered as 2 half doses (separated by at least 4 weeks for TIV and at least 6 weeks for LAIV).

Here's a link to the Centers for Disease Controls' Patient Information for the Flu Vaccine

Influenza vaccine: Adults

RECOMMENDED, when vaccine is available, for:

Medical indications:

• chronic disorders of the cardiovascular or pulmonary systems, including asthma;
• chronic metabolic diseases, including diabetes mellitus, renal dysfunction, hemoglobinopathies, or immunosuppression (including immunosuppression caused by medications or by human immunodeficiency virus [HIV]);
• pregnancy during the influenza season.
• age >=65

Occupational indications:

• health-care workers and employees of long-termñcare and assisted living facilities.

Other indications:

• residents of nursing homes and other long-termñcare facilities;
• persons likely to transmit influenza to persons at high risk (i.e., in-home caregivers to persons with medical indications, household/close contacts and out-of-home caregivers of children aged 0ñ23 months, household members and
• caregivers of elderly persons and adults with high-risk conditions);

and OPTIONAL can be given to ANYONE who wishes to be vaccinated

Here's a link to the Centers for Disease Controls' Patient Information for the Flu Vaccine

Pneumonia

RECOMMENDED for ALL patients >=65

If under age 65:

Medical indications:

• chronic disorders of the pulmonary system (excluding asthma);
• cardiovascular diseases;
• diabetes mellitus;
• chronic liver diseases, including liver disease as a result of alcohol abuse (e.g., cirrhosis);
• chronic renal failure or nephrotic syndrome;
• functional or anatomic asplenia (e.g., sickle cell disease or splenectomy);
• immunosuppressive conditions (e.g., congenital immunodeficiency, HIV infection, leukemia,lymphoma, multiple myeloma, Hodgkins disease, generalized malignancy, or organ or bone marrow transplantation);
• chemotherapy with alkylating agents, antimetabolites, or long-term systemic corticosteroids;

• cochlear implants.

Geographic/other indications:

• Alaska Natives and certain American Indian populations.

Other indications:

• Residents of nursing homes and other long-termñcare facilities

Revaccination with pneumococcal polysaccharide vaccine.

One-time revaccination after 5 years for persons with:

• chronic renal failure or nephrotic syndrome;
• functional or anatomic asplenia (e.g., sickle cell disease or splenectomy);
• immunosuppressive conditions (e.g., congenital immunodeficiency, HIV infection, leukemia, lymphoma, multiple myeloma, Hodgkins disease, generalized malignancy, or organ or bone marrow transplantation);
• or chemotherapy with alkylating agents, antimetabolites, or long-term systemic corticosteroids.

For persons aged >65 years, one-time revaccination ONLY if they were vaccinated >5 years previously AND were aged <65 years at the time of primary vaccination